BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 28408805)

  • 21. Berberine improves kidney function in diabetic mice via AMPK activation.
    Zhao L; Sun LN; Nie HB; Wang XL; Guan GJ
    PLoS One; 2014; 9(11):e113398. PubMed ID: 25409232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy.
    Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H
    Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Danggui-Shaoyao-San-Containing Serum on the Renal Tubular Epithelial-Mesenchymal Transition of Diabetic Nephropathy.
    Xiaobing L; Chunling N; Wenyu C; Yan C; Zhenzhen L
    Curr Pharm Biotechnol; 2020; 21(12):1204-1212. PubMed ID: 32297575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
    Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
    Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collagen VIII influences epithelial phenotypic changes in experimental diabetic nephropathy.
    Loeffler I; Liebisch M; Wolf G
    Am J Physiol Renal Physiol; 2012 Sep; 303(5):F733-45. PubMed ID: 22759394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-Mobility Group Nucleosome-Binding Protein 1 Mediates Renal Fibrosis Correlating with Macrophages Accumulation and Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy Mice Model.
    Yu J; Dong R; Da J; Li J; Yu F; Zha Y
    Kidney Blood Press Res; 2019; 44(3):331-343. PubMed ID: 31203283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the molecular mechanism of berberine for treating diabetic nephropathy based on network pharmacology.
    Yang L; Yuan S; Wang R; Guo X; Xie Y; Wei W; Tang L
    Int Immunopharmacol; 2024 Jan; 126():111237. PubMed ID: 37977063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GSK-3β inhibitor attenuates urinary albumin excretion in type 2 diabetic db/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytes.
    Wan J; Li P; Liu DW; Chen Y; Mo HZ; Liu BG; Chen WJ; Lu XQ; Guo J; Zhang Q; Qiao YJ; Liu ZS; Wan GR
    Mol Med Rep; 2016 Aug; 14(2):1771-84. PubMed ID: 27357417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy.
    Bai X; Geng J; Zhou Z; Tian J; Li X
    Sci Rep; 2016 Feb; 6():20475. PubMed ID: 26837280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-124a enhances therapeutic effects of bone marrow stromal cells transplant on diabetic nephropathy-related epithelial-to-mesenchymal transition and fibrosis.
    Cai X; Wang L; Wang X; Hou F
    J Cell Biochem; 2020 Jan; 121(1):299-312. PubMed ID: 31190436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759.
    Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q
    Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
    Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
    Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms.
    Ni WJ; Ding HH; Tang LQ
    Eur J Pharmacol; 2015 Aug; 760():103-12. PubMed ID: 25912800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis.
    Yang T; Shu F; Yang H; Heng C; Zhou Y; Chen Y; Qian X; Du L; Zhu X; Lu Q; Yin X
    Metabolism; 2019 Jul; 96():33-45. PubMed ID: 31028762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein arginine methyltranferase-1 induces ER stress and epithelial-mesenchymal transition in renal tubular epithelial cells and contributes to diabetic nephropathy.
    Chen YY; Peng XF; Liu GY; Liu JS; Sun L; Liu H; Xiao L; He LY
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2563-2575. PubMed ID: 31199999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical role of serum response factor in podocyte epithelial-mesenchymal transition of diabetic nephropathy.
    Zhao L; Wang X; Sun L; Nie H; Liu X; Chen Z; Guan G
    Diab Vasc Dis Res; 2016 Jan; 13(1):81-92. PubMed ID: 26408645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
    Lee YJ; Han HJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epiberberine ameliorated diabetic nephropathy by inactivating the angiotensinogen (Agt) to repress TGFβ/Smad2 pathway.
    Xiao Y; Deng J; Li C; Gong X; Gui Z; Huang J; Zhang Y; Liu Y; Ye X; Li X
    Phytomedicine; 2021 Mar; 83():153488. PubMed ID: 33571918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roscovitine attenuates renal interstitial fibrosis in diabetic mice through the TGF-β1/p38 MAPK pathway.
    Wang S; Zhou Y; Zhang Y; He X; Zhao X; Zhao H; Liu W
    Biomed Pharmacother; 2019 Jul; 115():108895. PubMed ID: 31029000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M; Liu M; Xiong M; Gong J; Tan X
    J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.